根据名称进行药物检索

Nifedical XL与冠状动脉疾病

Nifedical XL与冠状动脉疾病安全配伍检测的结果。

检测结果:

Nifedical XL <> 冠状动脉疾病

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

频率增加，持续时间和/或严重性的心绞痛，以及急性心肌梗塞，有很少的开发期间的开始或剂量增加钙的通道阻滞剂(建行)，特别是在患者具有严重性阻塞性冠状动脉疾病和那些处理立即释制剂。该机构的这种影响是不成立的。治疗与建行应给予谨慎的患者显着的冠状动脉疾病。

来源

Thomassen AR, Bagger JP, Nielsen TT "Hemodynamic and cardiac metabolic changes during nicardipine-induced myocardial ischemia." Cathet Cardiovasc Diagn 14 (1988): 41-3
Myrhed M, Wiholm B-E "Nifedipine: a survey of adverse effects." Acta Pharmacol Toxicol (Copenh) 58 (1986): 133-6
Lambert CR, Hill JA, Feldman RL, Pepine CJ "Myocardial ischemia during intravenous nicardipine administration." Am J Cardiol 55 (1985): 844-5
Furberg CD, Psaty BM, Meyer JV "Nifedipine: dose-related increase in mortality in patients with coronary heart disease." Circulation 92 (1995): 1326-31
Sia STB, MacDonald PS, Triester B, et al "Aggravation of myocardial ischaemia by nifedipine." Med J Aust 142 (1985): 48-50
"Product Information. Procardia (nifedipine)." Pfizer US Pharmaceuticals, New York, NY.
"Product Information. Sular (nisoldipine)." Zeneca Pharmaceuticals, Wilmington, DE.
Yusuf S "Calcium antagonists in coronary artery disease and hypertension: time for reevaluation?" Circulation 92 (1995): 1079-82
Kloner RA "Nifedipine in ischemic heart disease." Circulation 92 (1995): 1074-8
Manga P, Vythilingum "Unstable angina precipitated by nifedipine." S Afr Med J 66 (1984): 144
Abernathy DR, Schwrtz JB "Calcium-antagonist drugs." N Engl J Med 341 (1999): 1447-57
Oei SG, Oei SK, Brolmann HAM "Myocardial infarction during nifedipine therapy for preterm labor." N Engl J Med 340 (1999): 154
"Product Information. Cardene (nicardipine)." Syntex Laboratories Inc, Palo Alto, CA.
Schanzenbacher P, Deeg P, Liebau G, Kochsiek K "Paradoxical angina after nifedipine: angiographic documentation." Am J Cardiol 53 (1984): 345-6
"Product Information. Norvasc (amlodipine)." Pfizer US Pharmaceuticals, New York, NY.